Literature DB >> 2920789

Controlled release of dopamine from a polymeric brain implant: in vitro characterization.

A Freese1, B A Sabel, W M Saltzman, M J During, R Langer.   

Abstract

A biocompatible polymeric matrix system for the long-term controlled release of dopamine has been developed. Solid particles of this bioactive agent were encapsulated in ethylene-vinyl acetate copolymer (EVAc). Following immersion in an aqueous buffer solution, the release rate of dopamine from the polymer matrix was found to depend on the initial concentration of dopamine in the polymer. After coating the matrix devices with an additional impermeable layer of EVAc, constant rates of release were obtained by creating a cavity in this impermeable layer. The observed experiments are consistent with a diffusion-limited model of dopamine release; all the in vitro experimental results were therefore correlated by the effective diffusion coefficient of dopamine through the porous polymer network. These results are discussed in terms of potential design modifications to achieve desired release characteristics for a variety of neuroactive substances, including neurotransmitters or their precursors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2920789     DOI: 10.1016/0014-4886(89)90047-2

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  6 in total

Review 1.  Approaches to neural tissue engineering using scaffolds for drug delivery.

Authors:  Stephanie M Willerth; Shelly E Sakiyama-Elbert
Journal:  Adv Drug Deliv Rev       Date:  2007-04-10       Impact factor: 15.470

Review 2.  Adenosine augmentation therapies (AATs) for epilepsy: prospect of cell and gene therapies.

Authors:  Detlev Boison
Journal:  Epilepsy Res       Date:  2009-05-09       Impact factor: 3.045

3.  Infection of cultured striatal neurons with a defective HSV-1 vector: implications for gene therapy.

Authors:  A Freese; A Geller
Journal:  Nucleic Acids Res       Date:  1991-12       Impact factor: 16.971

Review 4.  The application of 5-bromodeoxyuridine in the management of CNS tumors.

Authors:  A Freese; D O'Rourke; K Judy; M J O'Connor
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

5.  Systemic delivery of blood-brain barrier-targeted polymeric nanoparticles enhances delivery to brain tissue.

Authors:  Jennifer K Saucier-Sawyer; Yang Deng; Young-Eun Seo; Christopher J Cheng; Junwei Zhang; Elias Quijano; W Mark Saltzman
Journal:  J Drug Target       Date:  2015       Impact factor: 5.121

6.  Catecholamine-containing biodegradable microsphere implants as a novel approach in the treatment of CNS neurodegenerative disease. A review of experimental studies in DA-lesioned rats.

Authors:  A McRae; E A Ling; S Hjorth; A Dahlström; D Mason; T Tice
Journal:  Mol Neurobiol       Date:  1994 Aug-Dec       Impact factor: 5.590

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.